MacroGenics, Inc.
MacroGenics, Inc. is named on 0 US grants and 10 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 0
- Published applications
- 10
- Inventors
- 14
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 3 |
| 2005 | 0 | 3 |
| 2006 | 0 | 0 |
| 2007 | 0 | 4 |
By publication year.
Technology areas
Share of 10 documents
- C07KPeptides10
- A61PTherapeutic uses of medicines8
- A61KMedicines and medical preparations7
- C12NMicroorganisms or enzymes3
- A01KAnimal husbandry2
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
Recent patents
No granted patents yet.
- Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity5 Apr 2007US 2007/0077246 A1
- Identification and engineering of antibodies with variant Fc regions and methods of using same15 Feb 2007US 2007/0036799 A1
- Dual expression vector system for antibody expression in bacterial and mammalian cells15 Feb 2007US 2007/0037216 A1
- Covalent diabodies and uses thereof4 Jan 2007US 2007/0004909 A1
- Fcgamma riib specific antibodies and methods of use thereof29 Sep 2005US 2005/0215767 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.